戻る
RemeGen Co., Ltd. (09995.HK)価格
09995.HK 株価推移チャート
REMEGEN (09995.HK)
RemeGen Co., Ltd.
HK$92.85
-2.57%
$-2.45
レギュラーマーケット： Jan 20, 11:22:57 HKT
主要データ
前終値
$95.2
始値
$95.3
当日レンジ
$92 - $95.8
52週レンジ
$11.52 - $126.6
取引高
3.7M
平均取引高
5.2M
1株当たり利益(TTM)
-2.35
配当利回り
--
時価総額
$19.3B
REMEGENとは何ですか？
RemeGen Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Yantai, Shandong and currently employs 2,999 full-time employees. The company went IPO on 2020-11-09. RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The firm focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The firm's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The firm mainly operates its businesses in the domestic and overseas markets.